# OnCo record rejuv-frontier-nad-infusions (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-frontier-nad-infusions/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-frontier-nad-infusions" ;
  schema:name "Intravenous NAD+ drips"@en ;
  schema:description "An NAD+ drip takes several hours, is sold in courses, and has never been tested against placebo for anything a cancer survivor would recognise. The published human literature on intravenous NAD+ amounts to retrospective series and narrative reviews."@en ;
  schema:url <https://onco.cc/technologies/rejuv-frontier-nad-infusions/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Nicotinamide_adenine_dinucleotide> ;
  schema:citation <https://doi.org/10.3389/fragi.2026.1887175>, <https://doi.org/10.1038/s41467-023-43514-6> ;
  onco:status "emerging" ;
  onco:tag "rejuvenation", "survivorship", "evidence:insufficient", "unproven", "supplement" ;
  onco:related <https://onco.cc/technologies/rejuv-frontier-nad-precursors/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/alternative-medicine-instead-of-treatment/> ;
  onco:drugs <https://onco.cc/drugs/nicotinamide/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/> .